You limited your search to:

 Resource Type: Report
 Collection: Congressional Research Service Reports
Background and Legal Issues Related to Stem Cell Research

Background and Legal Issues Related to Stem Cell Research

Date: June 12, 2002
Creator: Duffy, Diane T
Description: In August 2001, President Bush announced that federal funds, with certain restrictions, may be used to conduct research on human embryonic stem cells. Federal research is limited to “the more than 60” existing stem cell lines that were derived (1) with the informed consent of the donors; (2) from excess embryos created solely for reproductive purposes; and (3) without any financial inducements to the donors. No federal funds may be used for the derivation or use of stem cell lines derived from newly destroyed embryos; the creation of any human embryos for research purposes; or cloning of human embryos for any purposes.
Contributing Partner: UNT Libraries Government Documents Department
Background and Legal Issues Related to Stem Cell Research

Background and Legal Issues Related to Stem Cell Research

Date: October 26, 2004
Creator: Shimabukuro, Jon O.
Description: This report discusses issues regarding stem cell research. With certain restrictions, the President has announced that federal funds may be used to conduct research on human embryonic stem cells. Federal research is limited to "the more than 60" existing stem cell lines that were derived (1) with the informed consent of the donors; (2) from excess embryos created solely for reproductive purposes; and (3) without any financial inducements to the donors. No federal funds will be used for the derivation or use of stem cell lines derived from newly destroyed embryos; the creation of any human embryos for research purposes; or cloning of human embryos for any purposes.
Contributing Partner: UNT Libraries Government Documents Department
Beneficiary Information and Decision Supports for the Medicare-Endorsed Prescription Drug Discount Card

Beneficiary Information and Decision Supports for the Medicare-Endorsed Prescription Drug Discount Card

Date: March 24, 2005
Creator: Justice, Diane
Description: On December 8, 2003 the President signed into law the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA, P.L. 108-173). This legislation establishes a Medicare prescription drug benefit, effective January 1, 2006. In the interim, the legislation requires the Department of Health and Human Services (HHS) to establish a temporary program of Medicare-endorsed prescription drug discount cards. This report discusses the objectives and benefits of this legislation.
Contributing Partner: UNT Libraries Government Documents Department
Biotechnology: Commercialization of Academic Research

Biotechnology: Commercialization of Academic Research

Date: October 26, 1981
Creator: Johnson, Judith A
Description: This report provides an overview of the commercialization of academic research h in the field of biotechnology. It offers a brief definition, background and policy analysis, as well as legislation and hearings regarding the topic.
Contributing Partner: UNT Libraries Government Documents Department
Biotechnology, Indigenous Peoples, and Intellectual Property Rights

Biotechnology, Indigenous Peoples, and Intellectual Property Rights

Date: April 16, 1993
Creator: Axt, Josephie R; Lee, Margaret Mikyung & Ackerman, David M
Description: This report examines intellectual property right in pharmaceuticals in a particular context, namely, medicinal products and processes derived from the biodiversity resources of areas inhabited by indigenous peoples. This report discusses the international law regarding intellectual property rights in traditional knowledge and the American laws regarding traditional knowledge.
Contributing Partner: UNT Libraries Government Documents Department
Bisphenol A (BPA) in Plastics and Possible Human Health Effects

Bisphenol A (BPA) in Plastics and Possible Human Health Effects

Date: August 13, 2010
Creator: Schierow, Linda-Jo & Lister, Sarah A.
Description: This report discusses Bisphenol A (BPA). BPA is used to produce certain types of plastic that are used in thousands of formulations for myriad products. Containers made with these plastics may expose people to small amounts of BPA in food and water. Medical devices and other more ubiquitous products, such as thermal paper coatings, also may contribute significantly to human exposure. Some animal experiments have found that fetal and infant development may be harmed by small amounts of BPA, but scientists disagree about the value of the animal studies for predicting harmful effects in people.
Contributing Partner: UNT Libraries Government Documents Department
Bisphenol A (BPA) in Plastics and Possible Human Health Effects

Bisphenol A (BPA) in Plastics and Possible Human Health Effects

Date: June 30, 2008
Creator: Schierow, Linda-Jo & Lister, Sarah A.
Description: Bisphenol A (BPA) is used to produce certain types of plastic. Containers made of these plastics may expose people to small amounts of BPA in food and water. Some animal experiments have found that fetal and infant development may be harmed by small amounts of BPA, but scientists disagree about the value of the animal studies for predicting harmful effects in people. This report discusses this issue and relevant legislation, as well as inquiries into studies currently underway to determine the true harm inherent in BPA and the degree to which people are regularly exposed to BPA.
Contributing Partner: UNT Libraries Government Documents Department
Bisphenol A (BPA) in Plastics and Possible Human Health Effects

Bisphenol A (BPA) in Plastics and Possible Human Health Effects

Date: July 23, 2008
Creator: Schierow, Linda-Jo & Lister, Sarah A.
Description: Bisphenol A (BPA) is used to produce certain types of plastic. Containers made of these plastics may expose people to small amounts of BPA in food and water. Some animal experiments have found that fetal and infant development may be harmed by small amounts of BPA, but scientists disagree about the value of the animal studies for predicting harmful effects in people. This report discusses this issue and relevant legislation, as well as inquiries into studies currently underway to determine the true harm inherent in BPA and the degree to which people are regularly exposed to BPA.
Contributing Partner: UNT Libraries Government Documents Department
Bisphenol A (BPA) in Plastics and Possible Human Health Effects

Bisphenol A (BPA) in Plastics and Possible Human Health Effects

Date: September 8, 2008
Creator: Schierow, Linda-Jo & Lister, Sarah A.
Description: Bisphenol A (BPA) is used to produce certain types of plastic. Containers made of these plastics may expose people to small amounts of BPA in food and water. Some animal experiments have found that fetal and infant development may be harmed by small amounts of BPA, but scientists disagree about the value of the animal studies for predicting harmful effects in people. This report discusses this issue and relevant legislation, as well as inquiries into studies currently underway to determine the true harm inherent in BPA and the degree to which people are regularly exposed to BPA.
Contributing Partner: UNT Libraries Government Documents Department
A Brief Summary of the HIPAA Medical Privacy Rule

A Brief Summary of the HIPAA Medical Privacy Rule

Date: April 30, 2003
Creator: Stevens, Gina Marie
Description: This report provides a brief overview of the modified HIPAA Privacy rule, “Standards for the Privacy of Individually Identifiable Health Information” (“privacy rule”) published on August 14, 2002 by the Department of Health and Human Services (HHS).
Contributing Partner: UNT Libraries Government Documents Department
A Brief Summary of the Medical Privacy Rule

A Brief Summary of the Medical Privacy Rule

Date: February 14, 2003
Creator: Stevens, Gina Marie
Description: This report provides a brief overview of the modified medical privacy rule, “Standards for the Privacy of Individually Identifiable Health Information”(“privacy rule”) published on August 14, 2002 by the Department of Health and Human Services (HHS). The privacy regulation creates a new federal floor of privacy protections while leaving in place more protective state rules or practices. The rule establishes a set of basic consumer protections and a series of regulatory permissions for uses and disclosures of protected health information.
Contributing Partner: UNT Libraries Government Documents Department
A Brief Summary of the Medical Privacy Rule

A Brief Summary of the Medical Privacy Rule

Date: August 27, 2002
Creator: Stevens, Gina Marie
Description: This report provides a brief overview of the recently modified medical privacy rule, “Standards for the Privacy of Individually Identifiable Health Information”(“privacy rule”) published on August 14, 2002 by the Department of Health and Human Services (HHS). The privacy rule went into effect April 14, 2001, with compliance required by April 2003 for most entities. The regulation creates a new federal floor of privacy protections while leaving in place more protective state rules or practices. The rule establishes a set of basic consumer protections and a series of regulatory permissions for uses and disclosures of protected health information.
Contributing Partner: UNT Libraries Government Documents Department
A Brief Summary of the Medical Privacy Rule

A Brief Summary of the Medical Privacy Rule

Date: April 10, 2002
Creator: Stevens, Gina Marie
Description: On March 27, 2002 the Department of Health and Human Services (HHS) published its proposed changes to the medical privacy regulations issued by the Clinton Administration under the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”). HHS is accepting comments on the proposed changes until April 26, 2002. This report provides an overview of the final rule for “Standards for the Privacy of Individually Identifiable Health Information” ( “privacy rule”) that went into effect on April 14, 2001, and an overview of the Bush Administration’s proposed changes to the privacy regulation.
Contributing Partner: UNT Libraries Government Documents Department
Cancer Research: Selected Federal Spending and Morbidity and Mortality Statistics

Cancer Research: Selected Federal Spending and Morbidity and Mortality Statistics

Date: March 3, 1998
Creator: Johnson, Judith A
Description: This report shows federal spending at the National Institutes of Health (NIH) for research on selected cancer sites.
Contributing Partner: UNT Libraries Government Documents Department
Centers for Disease Control and Prevention Global Health Programs: FY2001-FY2010

Centers for Disease Control and Prevention Global Health Programs: FY2001-FY2010

Date: August 21, 2009
Creator: Salaam-Blyther, Tiaji
Description: This report explains the role the Centers for Disease Control and Prevention (CDC) plays in U.S. global health assistance, highlights how much the agency has spent on global health efforts from FY2001 to FY2010, and discusses how funding to each of its programs changed during this period.
Contributing Partner: UNT Libraries Government Documents Department
Centers for Disease Control and Prevention Global Health Programs: FY2001-FY2011

Centers for Disease Control and Prevention Global Health Programs: FY2001-FY2011

Date: April 7, 2010
Creator: Salaam-Blyther, Tiaji
Description: This report explains the role the Centers for Disease Control and Prevention (CDC) plays in U.S. global health assistance, highlights how much the agency has spent on global health efforts from FY2001 to FY2010, and discusses how funding to each of its programs has changed during this period.
Contributing Partner: UNT Libraries Government Documents Department
The Changing Demographic Profile of the United States

The Changing Demographic Profile of the United States

Date: May 5, 2006
Creator: Shrestha, Laura B
Description: As noted by the Population Reference Bureau, “The U.S. is getting bigger, older, and more diverse.” The objective of this report is to highlight some of the demographic changes that have already occurred since 1950 and to illustrate how these and future trends will reshape the nation in the decades to come (through 2050). This report discusses the current and projected demographic changes if policymakers accelerate efforts to address and adapt to the changing population profile as it relates to a number of essential domains, such as work, retirement, and pensions, private wealth and income security, and the health and well-being of the aging population.
Contributing Partner: UNT Libraries Government Documents Department
Cloning: A Select Chronology, 1997-2003

Cloning: A Select Chronology, 1997-2003

Date: July 9, 2003
Creator: Wright, Mary V
Description: This report includes a selected chronology of the events surrounding and following the cloning of a sheep from a single adult sheep cell by Scottish scientists, which was announced in February 1997. The project was cosponsored by PPL Therapeutics, Edinburgh, Scotland, which has applied for patents for the techniques used. This chronology also addresses subsequent reports of other cloning experiments, including the first one using human cells. Information on presidential actions and legislative activities related to the ethical and moral issues surrounding cloning is provided, as well as relevant Web sites.
Contributing Partner: UNT Libraries Government Documents Department
Cloning: A Select Chronology, 1997-2003

Cloning: A Select Chronology, 1997-2003

Date: August 19, 2003
Creator: Wright, Mary V
Description: This report includes a selected chronology of the events surrounding and following the cloning of a sheep from a single adult sheep cell by Scottish scientists, which was announced in February 1997. The project was cosponsored by PPL Therapeutics, Edinburgh, Scotland, which has applied for patents for the techniques used. This chronology also addresses subsequent reports of other cloning experiments, including the first one using human cells. Information on presidential actions and legislative activities related to the ethical and moral issues surrounding cloning is provided, as well as relevant Web sites.
Contributing Partner: UNT Libraries Government Documents Department
Cloning: A Select Chronology, 1997-2003

Cloning: A Select Chronology, 1997-2003

Date: March 10, 2003
Creator: Wright, Mary V
Description: This report includes a selected chronology of the events surrounding and following the cloning of a sheep from a single adult sheep cell by Scottish scientists, which was announced in February 1997. The project was cosponsored by PPL Therapeutics, Edinburgh, Scotland, which has applied for patents for the techniques used. This chronology also addresses subsequent reports of other cloning experiments, including the first one using human cells. Information on presidential actions and legislative activities related to the ethical and moral issues surrounding cloning is provided, as well as relevant Web sites.
Contributing Partner: UNT Libraries Government Documents Department
Cloning: Where Do We Go From Here?

Cloning: Where Do We Go From Here?

Date: April 23, 1998
Creator: Stith-Coleman, Irene
Description: News in February 1997 that scientists in Scotland had succeeded in cloning an adult sheep ignited a worldwide debate. Of concern are the ethical and social implications of the potential application of cloning to produce human beings. In response to concerns about the potential application of cloning to produce humans, actions were taken by the Administration and Congress.
Contributing Partner: UNT Libraries Government Documents Department
Coal Excise Tax Refunds: United States v. Clintwood Elkhorn Mining Co.

Coal Excise Tax Refunds: United States v. Clintwood Elkhorn Mining Co.

Date: May 16, 2008
Creator: Lunder, Erika
Description: In 1998, a U.S. district court held that the imposition of the coal excise tax, or black lung excise tax, on coal destined for export was unconstitutional. The process of refunding the tax has been controversial. This is because some coal producers and exporters have attempted to bypass the limitations in the Internal Revenue Code's refund scheme for bringing suit under the Export Clause in the Court of Federal Claims, seeking damages from the United States in the amount of coal excise taxes paid. The Federal Circuit Court of Appeals held the court had jurisdiction under the Tucker Act to hear the suits and allowed them as an alternative to the Code's refund process. However, in a 2008 decision, United States v. Clintwood Elkhorn Mining Co., the Supreme Court unanimously held that taxpayers must comply with the Code's administrative refund process before bringing suit. Meanwhile, H.R. 1762 and S. 373 would provide an alternative method for taxpayers to receive coal excise tax refunds.
Contributing Partner: UNT Libraries Government Documents Department
Comparison of the Current World Trade Center Medical Monitoring and Treatment Program and the World Trade Center Health Program Proposed by Title I of H.R. 847

Comparison of the Current World Trade Center Medical Monitoring and Treatment Program and the World Trade Center Health Program Proposed by Title I of H.R. 847

Date: December 14, 2010
Creator: Szymendera, Scott & Lister, Sarah A.
Description: This report compares the current federally supported medical screening and treatment program offered to various persons affected by the terrorist attack on New York City on September 11, 2001, with the federal program proposed to be established by Title I of H.R. 847, the James Zadroga 9/11 Health and Compensation Act of 2010, as amended and passed by the House of Representatives.
Contributing Partner: UNT Libraries Government Documents Department
Comparison of the Current World Trade Center Medical Monitoring and Treatment Program and the World Trade Center Health Program Proposed by Title I of H.R. 847

Comparison of the Current World Trade Center Medical Monitoring and Treatment Program and the World Trade Center Health Program Proposed by Title I of H.R. 847

Date: September 2, 2010
Creator: Szymendera, Scott & Lister, Sarah A.
Description: This report compares the current federally supported medical screening and treatment program offered to various persons affected by the terrorist attack on New York City on September 11, 2001, with the federal program proposed to be established by Title I of H.R. 847, the James Zadroga 9/11 Health and Compensation Act of 2010, as amended and passed by the House of Representatives. The World Trade Center (WTC) Medical Monitoring and Treatment Program (MMTP) and the World Trade Center Health Program (WTCHP) are the specific programs compared in this report.
Contributing Partner: UNT Libraries Government Documents Department